VA
NHC icon

Verdad Advisers’s National Healthcare NHC Stock Holding History

Verdad Advisers’s Portfolio NHC Stock Details NHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Buy
+2,295
New +$421K 0.46% 80

Other funds holding NHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.07B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Verdad Advisers's NHC Position: Q2 2026 in Review

Verdad Advisers opened a new position in National Healthcare (NHC) in Q2 2026: 2,295 shares worth $485K. The stake represents 0.46% of the portfolio and ranks #80 among its holdings.

248 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Verdad Advisers held 2,295 shares of National Healthcare worth $485K as of Q2 2026.
  • National Healthcare was a new Verdad Advisers position in Q2 2026.
  • National Healthcare made up 0.46% of Verdad Advisers's portfolio in Q2 2026, its #80 holding.
  • 248 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.